11
Total investments
4
Early stage
5
Mid stage
2
Late stage
4y
Years active
Portfolio
11 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Privater Investor
Mar 2025
Die führende KI-Software für automatisiertes Recruiting mit unserer digitalen Mitarbeiterin Mona.
Privater Investor
Nov 2024
Nuuron is a VC backed, clinical stage neurotech company that develops the Memory-Pacemaker, a non-invasive, photonic neurostimulation to re-enable patients with Alzheimers Disease to store and recall memories again.
Privater Investor
Sep 2024
SAFIA Technologies is a spin-off of the Federal Institute for Materials Research and Testing (BAM). The project specialises in the development of antibody-based analysis kits (immunoassays) based on SAFIA technology. As a platform technology, the SAFIA technology is suitable for use in various application areas such as food, feed and environmental analysis.
Privater Investor
Oct 2023
AQUATY is a fully digital securitization platform designed for asset and wealth managers in private markets. We provide Securitization as a Service, enabling efficient, seamless transactions while ensuring full compliance with legal and regulatory standards.
Our comprehensive offering includes SPV setup, Feeder Funds, club-deals, and a complete securitization suite for private assets across all types, including venture capital, private equity, real estate, and debt. We also offer consulting services to optimize private market transactions.
Headquartered in Münster, Germany, AQUATY is backed by renowned investors, driving innovation in private market securitization.
Privater Investor
Oct 2023
Todays mobility is inefficient, inconvenient and not sustainable because we lack knowledge of how everyday mobility works.
MOTIONTAG creates seamless, sustainable and smart mobility. Our technology infers insights from smartphone sensors about how, when and where people use transport services. We deliver the intelligence to help our clients understand their customer behaviors, optimize existing transport systems and create new, seamless mobility experiences.
View our privacy policy here: https://motion-tag.com/en/privacy-policy/
Privater Investor
Sep 2023
Rausgegangen ist Deutschlands größte Plattform für Event- und Kulturempfehlungen.
Rausgegangen hat es sich zur Aufgabe gemacht, die Welt zu einem besseren Ort zu machen, indem durch Empfehlungen über Website und App Events dem richtigen Publikum präsentiert werden. Mit mehr als 4,7 Millionen Seitenansichten im Monat und mehr als 285.000 registrierten Nutzer:innen auf der Webseite und in der App ist Rausgegangen mittlerweile Deutschlands größte Platform für digitale Event-Empfehlungen.
Sie zeigen ihrer Community täglich die besten Events in Deutschland. Events können kostenlos auf Rausgegangen platziert werden. Die Plattform dient als nationales Netzwerk und wird von diversen und renommierten Veranstaltenden täglich genutzt.
Rausgegangen steht für vielfältige, diverse, nachhaltige und kulturfördernde Themen und ist ein lokaler Experte in Sachen Ausgehen.
Mit der ZENTRALE bietet Rausgegangen das All-In-One-Tool für Kultur, Clubs, Venues und Festivals - das digitale Rückgrat der Kulturszene.
Dabei setzt die Plattform Fokus auf individuelle Ticketing-Lösungen, Online VVK, Verlosungen, Gästelisten erstellen, eine eigene individualisierbare Scanner-App, Marketing-Features.
Rausgegangen glaubt an die magische, emotionale Kraft von echten Erlebnissen, die uns verbinden und glücklich machen. Künstler:innen und kreative Köpfe inspirieren die Marke und machen somit gemeinsam mit Rausgegangen die Welt verständlicher und diverser.
_____________________________________________
Rausgegangen is Germanys largest platform for event and cultural recommendations.
Rausgegangens mission is to make the world a better place by helping you present your events to the right audience.
Rausgegangen stands for diverse, sustainable and culture-promoting topics and is a local expert when it comes to going out. With ZENTRALE, Rausgegangen offers the all-in-one tool for event organizers, clubs, venues and festivals. So place your events now for free via the Rausgegangen-ZENTRALE.
Privater Investor
May 2023
Nephrolyx offers a precise and rapid measurement of the kidney function (true GFR). We provide hospitals and laboratories with an In-Vitro Diagnostic Test and a digital platform to measure the true GFR within only a few hours.
For the first time, physicians can detect renal diseases using the highest accuracy of GFR measurement and adapt an optimal treatment plan for patients. Especially nephrology, oncology, transplantation, and ICU patients can benefit from rapid and precise diagnostics.
The Nephrolyx IVDx is indicated for the in-vitro quantitative determination of serum iohexol concentration and calculation of the glomerular filtration rate (GFR). The principle of the test is based on Ultra-High-Performance-Liquid Chromatography using Ultra-Violet light.
Proprietary technology from Nephrolyx helps to improve treatment success for kidney patients. Given its low component cost, the Nephrolyx IVDx can also significantly enhance the performance of the entire healthcare system.
Privater Investor
Apr 2023
Founded in 2020, reignite is a social gaming app where you can create, download and share stylish digital and customizable gamer cards. But its not just about game cards and in-game stats. Its more about the holistic gamer persona with all their achievements, hobbies and connections, that one creates with the sum of their cards - their gamer identity.
reignite is a community of reputable, like-minded gamers that can find and match with their own instead of playing with toxic randoms. Join our mission and help us reignite the passion in online gaming communities.
Privater Investor
Apr 2023
With its innovative and comprehensive platform for medical software, Nia Health is helping to reduce the burden and stigmatization of people with chronic skin conditions.
The award winning eczema app Nia is the first product of the medical device manufacturer.
Privater Investor
Dec 2022
Berlin Angel Fund is a brand of BACB Beteiligungsgesellschaft mbH, the venture capital partner of Business Angels Club Berlin-Brandenburg e.V. (BACB).
We combine the structure and financial possibilities of a venture capital fund with direct access to the support, network and know-how of far more than 100 active Business Angels from across Germany.
Following the metaphore of the 2 wings of a Business Angel, we always invest our own money and offer ongoing personal guidance. This includes:
- active support from first money in to scaling of the business
- personally involved Business Angels with skin in the game
- direct access to hands on experience and know-how in (almost) all business sectors
- some of the most experienced Business Angels and industry experts - ticket sizes up to 200.000€ as lead- and co-investor over multiple financing-rounds
- vast network in the Berlin and German start-up ecosystem.
Our shareholders are members of BACB e.V. with whom we are closely cooperating to generate our dealflow.
Our personal experience as (serial-)founders, entrepreneurs and/or senior managers enables us to interact with founder teams on eye-level and to guide less experienced Business Angels towards more successful start-up investments.
Privater Investor
Mar 2022
Get to know like-minded people of your age and from your area in an uncomplicated way at a group meeting. Go out to eat, hike together or experience culture together - anything is possible. Meet5: You meet five new people. The app is aimed at the middle-aged generation with both feet on the ground. Meet5 is especially for those who like to try something new. Get to know each other in person without chatting for a long time beforehand. The focus of the app is on making new acquaintances, if it ever turns into something more, were still happy! Meet5 started in Frankfurt, but we now have a strong presence throughout Germany and our first communities in Switzerland and Austria.
Experience · 12 entries
All (12)
Investments (11)
2025
Privater Investor
Mar 2025
Die führende KI-Software für automatisiertes Recruiting mit unserer digitalen Mitarbeiterin Mona.
2024
Privater Investor
Nov 2024
Nuuron is a VC backed, clinical stage neurotech company that develops the Memory-Pacemaker, a non-invasive, photonic neurostimulation to re-enable patients with Alzheimers Disease to store and recall memories again.
Privater Investor
Sep 2024
SAFIA Technologies is a spin-off of the Federal Institute for Materials Research and Testing (BAM). The project specialises in the development of antibody-based analysis kits (immunoassays) based on SAFIA technology. As a platform technology, the SAFIA technology is suitable for use in various application areas such as food, feed and environmental analysis.
2023
Privater Investor
Oct 2023
AQUATY is a fully digital securitization platform designed for asset and wealth managers in private markets. We provide Securitization as a Service, enabling efficient, seamless transactions while ensuring full compliance with legal and regulatory standards.
Our comprehensive offering includes SPV setup, Feeder Funds, club-deals, and a complete securitization suite for private assets across all types, including venture capital, private equity, real estate, and debt. We also offer consulting services to optimize private market transactions.
Headquartered in Münster, Germany, AQUATY is backed by renowned investors, driving innovation in private market securitization.
Privater Investor
Oct 2023
Todays mobility is inefficient, inconvenient and not sustainable because we lack knowledge of how everyday mobility works.
MOTIONTAG creates seamless, sustainable and smart mobility. Our technology infers insights from smartphone sensors about how, when and where people use transport services. We deliver the intelligence to help our clients understand their customer behaviors, optimize existing transport systems and create new, seamless mobility experiences.
View our privacy policy here: https://motion-tag.com/en/privacy-policy/
Show all 12 entries ↓
Investment activity
2022–2025 · 11 investments
Recent (last 2 years)Earlier
